The DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.
Cannabinoid tolerance and dependence: A review of studies in laboratory animals
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ledent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Imperato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,614
Pharmacology of cannabinoid CB1 and CB2 receptors
Pertwee, R. G. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)82001-3 · Cited by 1,470
Molecular mechanisms of drug addiction
Nestler, E. J. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.031 · Cited by 1,108
Pharmacology and effects of cannabis: A brief review
Ashton, C. H. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.2.101 · Cited by 934
DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS
Gainetdinov, R. R., Premont, R. T., Bohn, L. M., Lefkowitz, R. J., & Caron, M. G. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144206 · Cited by 860
Cellular and Synaptic Adaptations Mediating Opioid Dependence
Williams, J. T., Christie, M. J., & Manzoni, O. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.299 · Cited by 848
Cognitive Functioning of Long-term Heavy Cannabis Users Seeking Treatment
Solowij, N. (2002) · JAMA · doi:10.1001/jama.287.9.1123 · Cited by 798
Cannabinoid physiology and pharmacology: 30 years of progress
Howlett, A. C., Breivogel, C. S., Childers, S. R., Deadwyler, S. A., Hampson, R. E., & Porrino, L. J. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.07.030 · Cited by 608
Cannabis: pharmacology and toxicology in animals and humans
ADAMS, I. B., & MARTIN, B. R. (1996) · Addiction · doi:10.1046/j.1360-0443.1996.911115852.x · Cited by 570
Review of the Validity and Significance of Cannabis Withdrawal Syndrome
Budney, A. J., Hughes, J. R., Moore, B. A., & Vandrey, R. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.1967 · Cited by 522
Activation of Corticotropin-Releasing Factor in the Limbic System During Cannabinoid Withdrawal
Rodrı́guez de Fonseca, F., Carrera, M. R. A., Navarro, M., Koob, G. F., & Weiss, F. (1997) · Science · doi:10.1126/science.276.5321.2050 · Cited by 499
Hollister, L. (1987) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(87)90030-4 · Cited by 497
Role of Corticotropin-Releasing Factor in Drug Addiction: Potential for Pharmacological Intervention
Logrip, M. L., Koob, G. F., & Zorrilla, E. P. (2011) · CNS Drugs · doi:10.2165/11587790-000000000-00000 · Cited by 476
A cannabinoid mechanism in relapse to cocaine seeking
De Vries, T. J., Shaham, Y., Homberg, J. R., Crombag, H., Schuurman, K., Dieben, J., Vanderschuren, L. J. M. J., & Schoffelmeer, A. N. M. (2001) · Nature Medicine · doi:10.1038/nm1001-1151 · Cited by 432
Kandel, D. (1997) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(96)01315-4 · Cited by 395
Pharmacological and biochemical interactions between opioids and cannabinoids
Manzanares, J., Corchero, J., Romero, J., Fernández-Ruiz, J. J., Ramos, J. A., & Fuentes, J. A. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01339-5 · Cited by 392
Endocannabinoid signaling system and brain reward: emphasis on dopamine
GARDNER, E. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.032 · Cited by 387
Marijuana withdrawal among adults seeking treatment for marijuana dependence.
Budney, A. J., Novy, P. L., & Hughes, J. R. (1999) · Addiction · doi:10.1046/j.1360-0443.1999.94913114.x · Cited by 348 · cited 1×
“Cannabis sativa derivatives, such as marijuana and hashish, are among the drugs of abuse whose consumption has higher prevalence, particularly among young people (Budney et al., 1999; Ashton, 2001).”
BackgroundBehavioral Neurobiology of Alcohol Addiction: Recent Advances and Challenges
Weiss, F., & Porrino, L. J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03332.2002 · Cited by 327
Cannabinoids and the gastrointestinal tract
PERTWEE, R. G. (2001) · Gut · doi:10.1136/gut.48.6.859 · Cited by 326
Cocaine dependence: a disease of the brain’s reward centers
Dackis, C. A., & O'Brien, C. P. (2001) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(01)00192-1 · Cited by 323
Does cannabis use encourage other forms of illicit drug use?
Fergusson, D. M., & Horwood, L. J. (2000) · Addiction · doi:10.1046/j.1360-0443.2000.9545053.x · Cited by 321
Sim, L. J., Hampson, R. E., Deadwyler, S. A., & Childers, S. R. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-24-08057.1996 · Cited by 312
Internalization and Recycling of the CB1 Cannabinoid Receptor
Hsieh, C., Brown, S., Derleth, C., & Mackie, K. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730493.x · Cited by 296
Breivogel, C. S., Childers, S. R., Deadwyler, S. A., Hampson, R. E., Vogt, L. J., & Sim‐Selley, L. J. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0732447.x · Cited by 273
Regulation of Cannabinoid CB1 Receptors in the Central Nervous System by Chronic Cannabinoids
Sim-Selley, L. J. (2003) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v15.i2.10 · Cited by 271
Marijuana Withdrawal in Humans: Effects of Oral THC or Divalproex
Haney, M., Hart, C. L., Vosburg, S. K., Nasser, J., Bennett, A., Zubaran, C., & Foltin, R. W. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300310 · Cited by 264
Adverse effects of cannabis on health: an update of the literature since 1996
Kalant, H. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.05.027 · Cited by 264
Sim, L., Selley, D., Dworkin, S., & Childers, Sr. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-08-02684.1996 · Cited by 263
Distinct Domains of the CB1 Cannabinoid Receptor Mediate Desensitization and Internalization
Jin, W., Brown, S., Roche, J. P., Hsieh, C., Celver, J. P., Kovoor, A., Chavkin, C., & Mackie, K. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-10-03773.1999 · Cited by 261
Abstinence symptoms following oral THC administration to humans
Haney, M., Ward, A. S., Comer, S. D., Foltin, R. W., & Fischman, M. W. (1999) · Psychopharmacology · doi:10.1007/s002130050848 · Cited by 261
Neurobiology of marijuana abuse
Abood, M. E., & Martin, B. R. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90064-d · Cited by 250
Cannabinoid Transmission and Reward-Related Events
Gardner, E. L., & Vorel, S. R. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0219 · Cited by 250
Zorrilla, E., Valdez, G., & Weiss, F. (2001) · Psychopharmacology · doi:10.1007/s002130100773 · Cited by 246
Heyser, C. J., Hampson, R. E., & Deadwyler, S. A. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10268-1 · Cited by 245
Cardiovascular Consequences of Marijuana Use
Sidney, S. (2002) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.2002.tb06005.x · Cited by 242
Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist
Gallate, J. E., Saharov, T., Mallet, P. E., & McGregor, I. S. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00170-3 · Cited by 235
Stress, Corticotropin‐releasing Factor, and Drug Addiction
KOOB, G. F. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07876.x · Cited by 231
Cannabinoids, hippocampal function and memory
Hampson, R. E., & Deadwyler, S. A. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00294-5 · Cited by 221
Tolerance and disposition of tetrahydrocannabinol in man.
Hunt, C. A., & Jones, R. T. (1980) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32251-2 · Cited by 219
Regulation of Opioid Receptor Activities
Law, P.-Y., & Loh, H. H. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38179-0 · Cited by 206
Cannabinoid Addiction: Behavioral Models and Neural Correlates
Maldonado, R., & Rodrı́guez de Fonseca, F. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03326.2002 · Cited by 205
Regional Differences in Cannabinoid Receptor/G-protein Coupling in Rat Brain
Breivogel, C. S., Sim, L. J., & Childers, S. R. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36967-8 · Cited by 202
De Vries, T. J., Homberg, J. R., Binnekade, R., Raasø, H., & Schoffelmeer, A. N. M. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1422-1 · Cited by 198
Solinas, M., Panlilio, L. V., Antoniou, K., Pappas, L. A., & Goldberg, S. R. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.047928 · Cited by 194
Hutcheson, D. M., Tzavara, E. T., Smadja, C., Valjent, E., Roques, B. P., Hanoune, J., & Maldonado, R. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702228 · Cited by 192
Mesolimbic dopaminergic decline after cannabinoid withdrawal
Diana, M., Melis, M., Muntoni, A. L., & Gessa, G. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.10269 · Cited by 192
Clinical Relevance of Cannabis Tolerance and Dependence
JONES, R. T., BENOWITZ, N. L., & HERNING, R. I. (1981) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1981.tb02589.x · Cited by 191
Chait, L. D., & Perry, J. L. (1994) · Psychopharmacology · doi:10.1007/bf02245075 · Cited by 189
Mechanism of Extracellular Signal-Regulated Kinase Activation by the CB1 Cannabinoid Receptor
Galve-Roperh, I., Rueda, D., Gómez del Pulgar, T., Velasco, G., & Guzmán, M. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.6.1385 · Cited by 185
Comparison of smoked marijuana and oral Δ 9 -tetrahydrocannabinol in humans
Hart, C., Ward, A., Haney, M., Comer, S., Foltin, R., & Fischman, M. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1231-y · Cited by 180
Comparative Effects of Alcohol and Marijuana on Mood, Memory, and Performance
Heishman, S. J., Arasteh, K., & Stitzer, M. L. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00456-x · Cited by 179
Oviedo, A., Glowa, J., & Herkenham, M. (1993) · Brain Research · doi:10.1016/0006-8993(93)90220-h · Cited by 179
Function of Cannabinoid Receptors in the Neuroendocrine Regulation of Hormone Secretion
Murphy, L. L., Muñoz, R. M., Adrian, B. A., & Villanúa, M. A. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0224 · Cited by 176
Agonist-Induced Internalization and Trafficking of Cannabinoid CB1Receptors in Hippocampal Neurons
Coutts, A. A., Anavi-Goffer, S., Ross, R. A., MacEwan, D. J., Mackie, K., Pertwee, R. G., & Irving, A. J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-07-02425.2001 · Cited by 175
De Fonseca, F. R., Gorriti, M. A., Fernández-Ruiz, J. J., Palomo, T., & Ramos, J. A. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90108-2 · Cited by 175
Valverde, O., Noble, F., Beslot, F., Daugé, V., Fournié‐Zaluski, M., & Roques, B. P. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01558.x · Cited by 173
Tsou, K., Patrick, S. L., & Walker, J. M. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00360-w · Cited by 173
Cadoni, C., Pisanu, A., Solinas, M., Acquas, E., & Chiara, G. (2001) · Psychopharmacology · doi:10.1007/s002130100875 · Cited by 168
Di Marzo, V., Berrendero, F., Bisogno, T., González, S., Cavaliere, P., Romero, J., Cebeira, M., Ramos, J. A., & Fernández‐Ruiz, J. J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741627.x · Cited by 168
Self-citationDependence on delta 9-tetrahydrocannabinol: studies on precipitated and abrupt withdrawal.
Aceto, M. D., Scates, S. M., Lowe, J. A., & Martin, B. R. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20781-9 · Cited by 168
von Sydow, K., Lieb, R., Pfister, H., Höfler, M., Sonntag, H., & Wittchen, H.-U. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00137-5 · Cited by 162
The relationship between cannabis use and other substance use in the general population
Degenhardt, L. J., Hall, W., & Lynskey, M. T. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00130-2 · Cited by 158
Predictors of cessation of marijuana use: an event history analysis
Chen, K. M., & Kandel, D. B. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00021-0 · Cited by 155
Protein Kinase C Disrupts Cannabinoid Actions by Phosphorylation of the CB1 Cannabinoid Receptor
García, D. E., Brown, S. M., Hille, B., & Mackie, K. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-08-02834.1998 · Cited by 155
Addictive potential of cannabinoids: the underlying neurobiology
Gardner, E. L. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00162-7 · Cited by 150
Romero, J., García‐Palomero, E., Castro, J. G., García-Gil, L., Ramos, J. A., & Fernández‐Ruíz, J. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00277-x · Cited by 150
Opioid reward mechanisms: a key role in drug abuse?
Herz, A. (1998) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-76-3-252 · Cited by 147
Endocrine Effects of Marijuana
Brown, T. T., & Dobs, A. S. (2002) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.2002.tb06008.x · Cited by 140
Endocannabinoids in cognition and dependence
Lichtman, A. H., Varvel, S. A., & Martin, B. R. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0351 · Cited by 138
Perkonigg, A., Lieb, R., Höfler, M., Schuster, P. M., Sonntag, H., & Wïttchen, H. (1999) · Addiction · doi:10.1046/j.1360-0443.1999.941116635.x · Cited by 137
Self-administration of cannabinoids by experimental animals and human marijuana smokers
Justinová, Z., Goldberg, S. R., Heishman, S. J., & Tanda, G. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.026 · Cited by 137
The endogenous cannabinoid system and the basal ganglia
Romero, J., Lastres‐Becker, I., de Miguel, R., Berrendero, F., Ramos, J. A., & Fernández‐Ruíz, J. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00253-x · Cited by 136
Study of cannabinoid dependence in animals
Maldonado, R. J. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00254-1 · Cited by 136
Development of cross-tolerance between delta 9-tetrahydrocannabinol, CP 55,940 and WIN 55,212.
Fan, F., Compton, D. M., Ward, S. J., Melvin, L. S., & Martin, B. R. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24023-x · Cited by 126
Romero, J., Berrendero, F., Manzanares, J., P�rez, A., Corchero, J., Fuentes, J., Fern�ndez-Ruiz, J. J., & Ramos, J. A. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199811)30:3<298::aid-syn7>3.0.co;2-6 · Cited by 126
CB1 receptor antagonist precipitates withdrawal in mice exposed to Delta9-tetrahydrocannabinol.
Cook, S. A., Lowe, J. A., III, & Martin, B. R. (1998) · PubMed · Cited by 126
Sim‐Selley, L. J., & Martin, B. R. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035618 · Cited by 125
CB receptor antagonists for the treatment of nicotine addiction
Cohen, C., Kodas, E., & Griebel, G. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.024 · Cited by 123
Endocannabinoid system and alcohol addiction: Pharmacological studies
Colombo, G., SERRA, S., VACCA, G., Carai, M. A. M., & GESSA, G. L. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.022 · Cited by 118
Lamarque, S., Taghzouti, K., & Simon, H. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00039-9 · Cited by 116
Wu, X., & French, E. D. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00140-9 · Cited by 116
Signaling pathways involved in the development of cannabinoid tolerance
Martin, B. R., Sim‐Selley, L. J., & Selley, D. E. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.04.005 · Cited by 115
Dependence on tetrahydrocannabinol in rhesus monkeys.
Beardsley, P. M., Balster, R. L., & Harris, L. S. (1986) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23582-0 · Cited by 111
Zhuang, S.-Y., Kittler, J. T., Grigorenko, E. V., Kirby, M. T., Sim, L. J., Hampson, R. E., Childers, S. R., & Deadwyler, S. A. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00232-0 · Cited by 110
Rubino, T., Viganò, D., Massi, P., & Parolaro, D. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752080.x · Cited by 108
Pertwee, R. G., Stevenson, L. A., & Griffin, G. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13989.x · Cited by 107
Time course for the induction and maintenance of tolerance to Δ9-tetrahydrocannabinol in mice
Bass, C. E., & Martin, B. R. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00150-7 · Cited by 104
Romero, J., García‐García, L., Fernández‐Ruíz, J., Cebeira, M., & Ramos, J. A. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00023-p · Cited by 100
Self-citationRinaldi, M. L., Duigou, A. L., Oustric, D., Barth, F., Bouaboula, M., Carayon, P., Casellas, P., & Fur, G. L. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37898-x · Cited by 98
Spontaneous and precipitated withdrawal with a synthetic cannabinoid, WIN 55212-2
Aceto, M. D. G., Scates, S. M., & Martin, B. R. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00873-1 · Cited by 98
Cannabinoids and Memory; Animal Studies
Castellano, C., Rossi‐Arnaud, C., Cestari, V., & Costanzi, M. (2003) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007033482670 · Cited by 97
Fan, F., Tao, Q., Abood, M. E., & Martin, B. R. (1996) · Brain Research · doi:10.1016/0006-8993(95)01113-7 · Cited by 97
Chronic CP-55,940 alters cannabinoid receptor mRNA in the rat brain
Rubino, T., Massi, P., Patrini, G., Venier, I., Giagnoni, G., & Parolaro, D. (1994) · Neuroreport · doi:10.1097/00001756-199412000-00022 · Cited by 93
Identification of Endocannabinoids and Cannabinoid CB1 Receptor mRNA in the Pituitary Gland
González, S. R., Manzanares, J., Berrendero, F., Wenger, T., Corchero, J., Bisogno, T., Romero, J., Fuentes, J. A., Marzo, V. D., Ramos, J. A., et al. (1999) · Neuroendocrinology · doi:10.1159/000054468 · Cited by 93
Dependence of mesolimbic dopamine transmission on Δ9-tetrahydrocannabinol
Tanda, G., Loddo, P., & Chiara, G. D. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00384-2 · Cited by 89
Cannabinoid CB1 Receptor Agonists Produce Cerebellar Dysfunction in Mice
Patel, S., & Hillard, C. J. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29579-3 · Cited by 87
Initiation, continuation or discontinuation of cannabis use in the general population
Hammer, T., & Vaglum, P. (1990) · British Journal of Addiction · doi:10.1111/j.1360-0443.1990.tb03720.x · Cited by 86
Abood, M. E., Sauss, C., Fan, F., Tilton, C. L., & Martin, B. R. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90546-6 · Cited by 85
Cannabinoid withdrawal is dependent upon PKA activation in the cerebellum
Tzavara, E. T., Valjent, E., Firmo, C., Nieto, M. M., Beslot, F., Defer, N., Roques, B. P., Hanoune, J., & Maldonado, R. J. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00971.x · Cited by 85
Behavioral sensitization to heroin by cannabinoid pretreatment in the rat
Pontieri, F. E., Monnazzi, P., Scontrini, A., Buttarelli, F. R., & Patacchioli, F. R. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01056-1 · Cited by 85
Cannabinoid/Opioid Crosstalk in the Central Nervous System
Corchero, J., Manzanares, J., & Fuentes, J. A. (2004) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v16.i12.170 · Cited by 85
Cui, S.-S., Bowen, R. C., Gu, G.-B., Hannesson, D. K., Yu, P. H., & Zhang, X. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09867.2001 · Cited by 84
FemándeZ-Ruiz, J. J., Muñoz, R. M., Romero, J., Villanúa, M. A., Makriyannis, A., & Ramos, J. A. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00168-8 · Cited by 83
Welch, S. P., Dunlow, L. D., Patrick, G., & Razdan, R. K. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09617-x · Cited by 79
Marijuana Withdrawal Syndrome in the Animal Model
Lichtman, A. H., & Martin, B. R. (2002) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.2002.tb05999.x · Cited by 78
Nava, F. A., Carta, G., Colombo, G., & Gessa, G. L. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00075-2 · Cited by 77
Rubino, T., Forlani, G., Viganò, D., Zippel, R., & Parolaro, D. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2003.11.003 · Cited by 76
The role of endocannabinoids in the hypothalamic regulation of visceral function
Wenger, T., & Moldrich, G. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0353 · Cited by 76
Wenger, Fernández‐Ruiz, & Ramos (1999) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1999.00402.x · Cited by 74
Regulation of adenylate cyclase by chronic exposure to cannabimimetic drugs.
Dill, J. A., & Howlett, A. C. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24581-5 · Cited by 71
Sarnyai, Z. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09011.x · Cited by 70
Rubino, T., Viganò, D., Massi, P., Spinello, M., Zagato, E., Giagnoni, G., & Parolaro, D. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00196-3 · Cited by 70
Cannabinoid-induced motor incoordination through the cerebellar CB1 receptor in mice
DeSanty, K. P., & Dar, M. S. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00539-1 · Cited by 69
Roche, J. P., Bounds, S., Brown, S. M., & Mackie, K. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.3.611 · Cited by 68
Anandamides: tolerance and cross-tolerance toΔ9-tetrahydrocannabinol
Fride, E. (1995) · Brain Research · doi:10.1016/0006-8993(95)00790-w · Cited by 67
Corchero, J., Romero, J., Berrendero, F., Fernández‐Ruíz, J., Ramos, J. A., Fuentes, J. A., & Manzanares, J. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00053-4 · Cited by 67
Carta, G., Nava, F. A., & GESSA, G. L. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00738-0 · Cited by 67
Georges, F. E., Stinus, L., & Moine, C. L. (2000) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2000.01334.x · Cited by 66
González, S. R., Fernández‐Ruíz, J., Marzo, V. D., Hernández, M., Arévalo, C., Nicanor, C., Cascio, M. G., Ambrosio, E., & Ramos, J. A. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2003.12.011 · Cited by 66
Endocannabinoids and basal ganglia functionality
Fernández‐Ruíz, J., Lastres‐Becker, I., Cabranes, A., González, S. R., & Ramos, J. A. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0350 · Cited by 65
Norwood, C. S., Cornish, J. L., Mallet, P. E., & McGregor, I. S. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01455-9 · Cited by 63
Rubino, T., Patrini, G., Parenti, M. D., Massi, P., & Parolaro, D. (1997) · Molecular Brain Research · doi:10.1016/s0006-8993(96)00941-9 · Cited by 63
Rhee, M. H., Nevo, I., Avidor‐Reiss, T., Levy, R., & Vogel, Z. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26475-0 · Cited by 60
Martin, B. R., Dewey, W. L., Harris, L. S., et al. (1976) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30393-9 · Cited by 58
ARE ANANDAMIDE AND CANNABINOID RECEPTORS INVOLVED IN ETHANOL TOLERANCE? A REVIEW OF THE EVIDENCE
Hungund, B. L. (2000) · Alcohol and Alcoholism · doi:10.1093/alcalc/35.2.126 · Cited by 58
Welch, S. P. (1997) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(97)01342-2 · Cited by 57
Endocrine effects of nicotine administration, tobacco and other drug withdrawal in humans
Pickworth, W. B., & Fant, R. V. (1998) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(97)00075-9 · Cited by 56
The effects of Δ9-tetrahydrocannabinol physical dependence on brain cannabinoid receptors
Breivogel, C. S., Scates, S. M., Beletskaya, I. O., Lowery, O. B., Aceto, M. D. G., & Martin, B. R. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02854-6 · Cited by 56
de Miguel, R., Romero, J., Muñoz, R. M., Garcı́a-Gil, L., González, S. R., Villanúa, M. Á., Makriyannis, A., Ramos, J. A., & Fernández‐Ruíz, J. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00185-3 · Cited by 55
Pillay, S. S., Rogowska, J., Kanayama, G., Jon, D., Gruber, S. A., Simpson, N. S., Cherayil, M., Pope, H. G., & Yurgelun-Todd, D. A. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.05.009 · Cited by 53
Shapira, M., Gafni, M., & Sarne, Y. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00697-0 · Cited by 52
Whitlow, C. T., Freedland, C. S., & Porrino, L. J. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1001-x · Cited by 52
Mishima, K., Egashira, N., Matsumoto, Y., Iwasaki, K., & Fujiwara, M. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)02274-9 · Cited by 52
Hampson, R. E., Simeral, J. D., Kelly, E. J., & Deadwyler, S. A. (2003) · Hippocampus · doi:10.1002/hipo.10081 · Cited by 51
Tolerance Develops to the Disruptive Effects of Δ 9 -Tetrahydrocannabinol on Primate Menstrual Cycle
Smith, C. G., Almirez, R. G., Berenberg, J. L., & Asch, R. H. (1983) · Science · doi:10.1126/science.6298938 · Cited by 50
Rubino, T., Vigan�, D., Zagato, E., Sala, M., & Parolaro, D. (2000) · Synapse · Cited by 50
Functional consequences of the repeated administration of Δ9-tetrahydrocannabinol in the rat
Whitlow, C. T. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00135-2 · Cited by 50
Freedland, C. S., Whitlow, C. T., Miller, M. D., & Porrino, L. J. (2002) · Synapse · doi:10.1002/syn.10089 · Cited by 49
Lack of Tolerance to Δ 9 -Tetrahydrocannabinol in Chimpanzees
Ferraro, D. P., & Grilly, D. M. (1973) · Science · doi:10.1126/science.179.4072.490 · Cited by 49
The Biological bases of drug tolerance and dependence
Pratt, J. (1991) · Cited by 48
de Fonseca, F. R., Fernández‐Ruíz, J., Murphy, L. L., Eldridge, J. C., Steger, R. W., & Bartke, A. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90368-c · Cited by 46
Rubino, T., Viganò, D., Costa, B., Colleoni, M., & Parolaro, D. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752478.x · Cited by 46
Precipitated and spontaneous withdrawal in rats tolerant to anandamide
Costa, B., Giagnoni, G., & Colleoni, M. (2000) · Psychopharmacology · doi:10.1007/s002139900360 · Cited by 44
Klein, R. L., & Harris, R. A. (1996) · Japanese Journal of Pharmacology · doi:10.1254/jjp.70.1 · Cited by 41
Chronic exposure toΔ9-tetrahydrocannabinol fails to irreversibly alter brain cannabinoid receptors
Westlake, T. M., Howlett, A. C., Ali, S. F., Paule, M. G., Scallet, A. C., & Slikker, W. (1991) · Brain Research · doi:10.1016/0006-8993(91)90897-5 · Cited by 41
Romero, J., Berrendero, F., García-Gil, L., Ramos, J. A., & Fernández‐Ruíz, J. (1998) · Journal of Molecular Neuroscience · doi:10.1385/jmn:11:2:109 · Cited by 41
Induction and genetic regulation of mouse hepatic cytochrome P450 by cannabidiol
Bornheim, L. M., Everhart, E. T., Li, J., & Correia, M. A. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90236-4 · Cited by 39
The endogenous cannabinoid system and the treatment of marijuana dependence
Piomelli, D. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.07.018 · Cited by 38
Behavioural and gene transcription alterations induced by spontaneous cannabinoid withdrawal in mice
Oliva, J. M., Ortiz, S., Palomo, T., & Manzanares, J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01627.x · Cited by 37
Shapira, M., Gafni, M., & Sarne, Y. (2003) · Brain Research · doi:10.1016/s0006-8993(02)03842-8 · Cited by 37
The psychoactive ingredient of marijuana induces behavioural sensitization
Rubino, T., Viganò, D., Massi, P., & Parolaro, D. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01709.x · Cited by 36
Cellular mechanisms of Δ9‐tetrahydrocannabinol behavioural sensitization
Rubino, T., Viganò, D., Massi, P., & Parolaro, D. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02452.x · Cited by 31
Patrini, G., Sacerdote, P., Fuzio, D., Manfredi, B., & Parolaro, D. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00149-5 · Cited by 28
Prostaglandin E2 attenuates SR141716A-precipitated withdrawal in tetrahydrocannabinol-dependent mice
Anggadiredja, K., Yamaguchi, T., Tanaka, H., Shoyama, Y., Watanabe, S., & Yamamoto, T. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04169-0 · Cited by 28
Marihuana-like activity of new synthetic tetrahydrocannabinols
Martin, B. R., Dewey, W. L., Harris, L. S., et al. (1975) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(75)90116-1 · Cited by 26
Changes in Rat Spleen Cannabinoid Receptors after Chronic CP-55,940: An Autoradiographic Study
Massi, P., Patrini, G., Rubino, T., et al. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00379-6 · Cited by 18
Cited by
Sommermeyer, D., Hudecek, M., Kosasih, P. L., Gogishvili, T., Maloney, D. G., Turtle, C. J., & Riddell, S. R. (2016) · Leukemia · doi:10.1038/leu.2015.247 · Cited by 867
Hirvonen, J., Goodwin, R. S., Li, C.-T., Terry, G. E., Zoghbi, S. S., Morse, C., Pike, V. W., Volkow, N. D., Huestis, M. A., & Innis, R. B. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.82 · Cited by 587
SVIZENSKA, I., DUBOVY, P., & SULCOVA, A. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.05.010 · Cited by 457
Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective
Cooper, Z. D., & Craft, R. M. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.140 · Cited by 350
The cannabis withdrawal syndrome
Budney, A. J., & Hughes, J. R. (2006) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000218592.00689.e5 · Cited by 349
Metadata
- Authors
- GONZALEZ, S., CEBEIRA, M., & FERNANDEZRUIZ, J.
- Venue
- Pharmacology Biochemistry and Behavior
- Publisher
- Elsevier BV
- Published
- 2005-06
- Volume
- 81
- Issue
- 2
- Pages
- 300-318
- ISSN
- 0091-3057 (ISSN-L)
- OpenAlex
- W2081987813
- Cited by
- 258
- References
- 157
- FWCI
- 7.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.